Missouri stem-cell ban possible

When Missouri's elected representatives arrived for the 2005 legislative session, they had their hands full of material about the ethics and implications of a proposed statewide ban on somatic cell nuclear transfer (SCNT).

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When Missouri's elected representatives arrived for the 2005 legislative session, they had their hands full of material about the ethics and implications of a proposed statewide ban on somatic cell nuclear transfer (SCNT). The material includes a letter from Rep. Jim Lembke, one of the bill's originators, describing what he says are the advantages of adult stem cells over embryonic stem cells, and the ethical problems with both reproductive and therapeutic cloning.

However, leaders from Missouri research institutions have sent their own letter to legislators, urging them to ban reproductive cloning but not SCNT. They argue that banning SCNT would undermine the state's life science industry. The letter is signed by William H. Danforth, chairman of the Donald Danforth Plant Science Center in St. Louis; Elson Floyd, president of the University of Missouri System; William Neaves, president of the Stowers Institute for Medical Research in Kansas City; and Mark S. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies